Bliss GVS Pharma Limited
Bliss GVS Pharma Limited
Aktie · INE416D01022 (XNSE)
Übersicht
Kein Kurs
Schlusskurs XNSE 30.01.2026: 176,30 INR
30.01.2026 09:59
Aktuelle Kurse von Bliss GVS Pharma Limited
BörseTickerWährungLetzter UmsatzKursTagesveränderung
XNSE: NSE
NSE
BLISSGVS.NS
INR
30.01.2026 09:59
176,30 INR
-6,83 INR
-3,73 %
XBOM: MSE
MSE
BLISSGVS.BO
INR
30.01.2026 09:59
176,85 INR
-6,28 INR
-3,43 %
Free Float & Liquidität
Free Float 39,65 %
Shares Float 41,95 M
Ausstehende Aktien 105,79 M
Firmenprofil zu Bliss GVS Pharma Limited Aktie
Bliss GVS Pharma Limited develops, manufactures, and markets pharmaceutical formulations in India. It offers pharma products, including capsules, creams/gels/ointments, dry powder for injections and oral suspensions, effervescent tablets, eye/ear drops, injections, liquid preparations, lotions, lozenges, nasal solutions, oral solids, parenterals, pessaries, sachets, soft gelatin capsules, suppositories, suspensions, syrups, tablets, topical preparations, and transdermal patches. The company provides other healthcare products, such as balms, creams, lotions, lozenges, nasal inhalers, over the counter products, petroleum jellies, powders, roll-ons, shampoos, soaps, solutions, sprays, syrups, and vaginal washes. In addition, it offers therapeutic products consisting of anti-bacterial, anti-dandruff shampoo, amino acid preparation, iron tonic, antitussive, appetite stimulant, anti-allergic, body supplement, anti-biotic, anti-diabetic, anti-diarrheal, anti-emetic, anti-fungal, anti-haemorrhoidal, anti-helmintic, anti-infective, anti-inflammatory, anti-malarial, anti-microbial, anti-migraine, anti-oxidant, anti-protozoal, ear wax solvent, anti-pyretic, anti-septic, anti-spasmodic, anti-ulcer, and anti-ulcerant; and analgesic, oral rehydration, antacid, anxiolytic, appetizer, cough syrup, erectile dysfunction, haematinic, hand sanitizer, health supplement, insecticide, laryngitis, pharyngitis, laxative, lubricant, mosquito repellant, nasal decongestant, nutritional supplement, moisturizer, prickly heat powder, skin lightening lotion, vaginal contraceptive, vaginal hygiene, and vitamin supplements, as well as soaps. The company exports its products. Bliss GVS Pharma Limited was incorporated in 1984 and is based in Mumbai, India.
KI-Analyse von Bliss GVS Pharma Limited
Wähle eine Analyse aus und der finAgent liefert dir tiefgehende Einblicke dazu!
Neuste KI Analysen zu Bliss GVS Pharma Limited
Für dieses Unternehmen sind noch keine KI-Threads verfügbar.

Unternehmensdaten

Name Bliss GVS Pharma Limited
Firma Bliss GVS Pharma Limited
Website https://www.blissgvs.com
Heimatbörse XNSE NSE
ISIN INE416D01022
Wertpapierart Aktie
Sektor Healthcare
Branche Drug Manufacturers - Specialty & Generic
CEO Shibroor Narsimha Kamath
Marktkapitalisierung 19 Mrd.
Land Indien
Währung INR
Mitarbeiter 0,8 T
Adresse 102, Hyde Park, 400072 Mumbai
IPO Datum 2002-01-11

Ticker Symbole

Name Symbol
MSE BLISSGVS.BO
NSE BLISSGVS.NS
Weitere Aktien
Investoren, die Bliss GVS Pharma Limited halten, haben auch folgende Aktien im Depot:
BML, Inc.
BML, Inc. Aktie
DEUTSCHE WN SE NEUE
DEUTSCHE WN SE NEUE Aktie
Die Finanzplattform MoneyPeak trackt und analysiert Investitionen und Portfolios. Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Impressum Datenschutz Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2026